EPHA1 (569 extrémité), actif, GST étiqueté humain, PRECISIO Kinase, recombinant, exprimé en cellules baculovirus infectées Sf9, >= 70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5026-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

EPHA1 is a member of the Eph family of receptor tyrosine kinases that have been implicated in mediating developmental events, particularly in the nervous ...


en savoir plus

Votre prix
$564.93 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

EPHA1 is a member of the Eph family of receptor tyrosine kinases that have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the Eph subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. EPHA1 seems to be a marker of the differentiated normal epidermis and its downregulation in nonmelanoma skin cancer may contribute to carcinogenesis of these very frequent human tumors. EPHA1 represents a new potential prognostic marker and therapeutic target in nonmelanoma skin cancer.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... EPHA1(2041)
mol wt~72 kDa
NCBI accession no.NM_005232
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity24-32 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: